Literature DB >> 15532032

A novel mutation in KCNA1 causes episodic ataxia without myokymia.

Hane Lee1, Hui Wang, Joanna C Jen, Chiara Sabatti, Robert W Baloh, Stanley F Nelson.   

Abstract

We describe a unique family in which several individual are affected with episodes of ataxia that best fit the phenotype of episodic ataxia type 2 (EA2). All of the affected family members had episodes typically lasting for several hours, and none of them had muscle abnormalities including myokymia. Episodic ataxia type 1 (EA1) was not considered initially as a clinical diagnosis for the affected individuals in this family. However, by linkage mapping, sequencing and polymorphism analysis, all affecteds were found to have a novel mutation in KCNA1. Numerous missense mutations have been described previously in KCNA1 that cause EA1. The mutation c.1025G>T replaces a highly conserved serine with isoleucine at position 342 (p.Ser342Ile) in the highly conserved fifth transmembrane domain of the KCNA1. This mutation leads to a distinct clinical phenotype without myokymia broadening the scope of clinical characteristics of EA1 and highlighting the heterogeneity of phenotypic effects from distinct missense mutations. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15532032     DOI: 10.1002/humu.9295

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  18 in total

1.  Chronic neuromyotonia as a phenotypic variation associated with a new mutation in the KCNA1 gene.

Authors:  A Poujois; J-Ch Antoine; A Combes; R L Touraine
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

2.  A case of intermittent ataxia associated with migraine headaches.

Authors:  Raymond C S Seet; Erle C H Lim
Journal:  CMAJ       Date:  2007-09-11       Impact factor: 8.262

Review 3.  The Clinical Spectrum of Autosomal-Dominant Episodic Ataxias.

Authors:  Stefan Kipfer; Michael Strupp
Journal:  Mov Disord Clin Pract       Date:  2014-07-28

4.  Kinesigenic Triggers in Episodic Ataxia Type 1.

Authors:  Claudio M de Gusmao; Lucas Rogerio Garcia; Aaron Jesuthasan; Meaghan Muir; Alex Paciorkowski; Jonathan W Mink; Laura Silveira-Moriyama
Journal:  Mov Disord Clin Pract       Date:  2020-07-19

5.  Functional analysis of a novel potassium channel (KCNA1) mutation in hereditary myokymia.

Authors:  Haijun Chen; Christian von Hehn; Leonard K Kaczmarek; Laura R Ment; Barbara R Pober; Fuki M Hisama
Journal:  Neurogenetics       Date:  2006-11-29       Impact factor: 2.660

Review 6.  Voltage-gated potassium channels at the crossroads of neuronal function, ischemic tolerance, and neurodegeneration.

Authors:  Niyathi Hegde Shah; Elias Aizenman
Journal:  Transl Stroke Res       Date:  2013-11-19       Impact factor: 6.829

7.  Functional analysis of the Kv1.1 N255D mutation associated with autosomal dominant hypomagnesemia.

Authors:  Jenny van der Wijst; Bob Glaudemans; Hanka Venselaar; Anil V Nair; Anna-Lena Forst; Joost G J Hoenderop; René J M Bindels
Journal:  J Biol Chem       Date:  2009-11-10       Impact factor: 5.157

8.  A missense mutation in the Kv1.1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia.

Authors:  Bob Glaudemans; Jenny van der Wijst; Rosana H Scola; Paulo J Lorenzoni; Angelien Heister; Annemiete W van der Kemp; Nine V Knoers; Joost G Hoenderop; René J Bindels
Journal:  J Clin Invest       Date:  2009-03-23       Impact factor: 14.808

Review 9.  Clinical Spectrum of KCNA1 Mutations: New Insights into Episodic Ataxia and Epilepsy Comorbidity.

Authors:  Kelsey Paulhus; Lauren Ammerman; Edward Glasscock
Journal:  Int J Mol Sci       Date:  2020-04-17       Impact factor: 5.923

Review 10.  Episodic ataxia type 1: a neuronal potassium channelopathy.

Authors:  Sanjeev Rajakulendran; Stephanie Schorge; Dimitri M Kullmann; Michael G Hanna
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.